Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
EGL Genetic Diagnostics, |
RCV000726352 | SCV000344016 | uncertain significance | not provided | 2016-07-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000726352 | SCV000572182 | uncertain significance | not provided | 2016-11-15 | criteria provided, single submitter | clinical testing | The P3T variant in the COL4A1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The P3T variant was not observed with any significant frequency in the Exome Aggregation Consortium (ExAC) data set, indicating it is not a common benign variant. The P3T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across mammalian species. However, in silico analysis predicts this variant likely does not alter the protein structure/function. We interpret P3T as a variant of uncertain significance. |
Fulgent Genetics, |
RCV000763878 | SCV000894813 | uncertain significance | Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps; Brain small vessel disease with hemorrhage; Porencephaly 1; SCHIZENCEPHALY; Hemorrhage, intracerebral, susceptibility to; Retinal arteries, tortuosity of | 2018-10-31 | criteria provided, single submitter | clinical testing |